Comments on the letter by Pitocco et al. (Serum uric acid, mortality and glucose control in patients with type 2 diabetes mellitus: A PreCIS database study)

Diabetic Medicine

Volumn 25, Issue 4, 2008, Pages 509-

  Ioachimescu, A G ^a   Hoogwerf, B J ^a  

^a Department of ENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; GLUCOSE; NITRIC OXIDE; URIC ACID; XANTHINE OXIDASE;

CORRELATION ANALYSIS; DATA BASE; DISEASE COURSE; ENDOTHELIUM; ENZYME ACTIVITY; GLUCOSE METABOLISM; HUMAN; LETTER; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; URIC ACID BLOOD LEVEL; VASCULAR DISEASE;

EID: 41749091813     PISSN: 07423071     EISSN: 14645491     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2008.02393.x     Document Type: Letter

References (12)

1. Pitocco D, Zaccardi F, Di Stasio A, Romitelli A, Santini SA, Ghirlanda G. Serum uric acid, mortality and glucose control in patients with Type 2 diabetes mellitus: a PreCIS database study. Diabetic Med 2008 [E pub ahead of print] doi:.
2. Ioachimescu AG, Brennan DM, Hoar BM, Kashyap SR, Hoogwerf BJ. Serum uric acid, mortality and glucose control in patients with Type 2 diabetes mellitus: a PreCIS database study. Diabet Med 2007 24 : 1369 1374.
3. Waring WS, McKnight JA, Webb DJ, Maxwell SR. Lowering serum urate does not improve endothelial function in patients with type 2 diabetes. Diabetologia 2007 50 : 2572 2579.
4. Nakagawa T, Hu H, Zharikov S, Tuttle KR, Short GA, Glushkova O et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006 290 : F625 F631.
5. Khosla UM, Zharikov S, Finch JL, Nakagawa T, Roncal C, Mu W et al. Hyperuricemia induces endothelial dysfunction. Kidney Int 2005 67 : 1739 1742.
6. Rao GN, Corson MA, Berk BC. Uric acid stimulates vascular smooth muscle cell proliferation by increasing platelet-derived growth factor A-chain expression. J Biol Chem 1991 266 : 8604 8608.
7. Kang DH, Park SK, Lee IK, Johnson RJ. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005 16 : 3553 3562.
8. Bagnati M, Perugini C, Cau C, Bordone R, Albano E, Bellomo G. When and why a water-soluble antioxidant becomes pro-oxidant during copper-induced low-density lipoprotein oxidation: a study using uric acid. Biochem J 1999 340 : 143 152.
9. Sautin YY, Nakagawa T, Zharikov S, Johnson RJ. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH oxidase-mediated oxidative/nitrosative stress. Am J Physiol Cell Physiol 2007 293 : C584 C596.
10. Waring WS, McKnight JA, Webb DJ, Maxwell SR. Uric acid restores endothelial function in patients with type 1 diabetes and regular smokers. Diabetes 2006 55 : 3127 3132.
11. Butler R, Morris AD, Belch JJ, Hill A, Struthers AD. Allopurinol normalizes endothelial dysfunction in type 2 diabetics with mild hypertension. Hypertension 2000 35 : 746 751.
12. Enomoto A, Endou H. Roles of organic anion transporters (OATs) and a urate transporter (URAT1) in the pathophysiology of human disease. Clin Exp Nephrol 2005 9 : 195 205.